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ABSTRACT
Background. A loss of mucosal tolerance to the resident microbiome has been
postulated in the aetiopathogenesis of spondyloarthritis, thus the purpose of these
studies was to investigatemicrobial communities that colonise the oral cavity of patients
with axial spondyloarthritis (AxSpA) and to compare these with microbial profiles of
a matched healthy population.
Methods. Thirty-nine participants, 17 patients with AxSpA and 22 age and gender-
matched disease-free controls were recruited to the study. For patients with AxSpA,
disease activity was assessed using the Bath Ankylosing Spondylitis Disease Activity
Index (BASDAI). All participants underwent a detailed dental examination to assess
oral health, including the presence of periodontal disease assessed using probing pocket
depth (PPD). Plaque samples were obtained and their bacterial populations were
profiled using Ion Torrent sequencing of the V6 region of the 16S rRNA gene.
Results. Patients withAxSpAhad active disease (BASDAI 4.1± 2.1 [mean± SD]), and a
significantly greater prevalence of periodontitis (PPD≥ 4mmat≥4 sites) than controls.
Bacterial communities did not differ between the two groups with multiple metrics of
α and β diversity considered. Analysis of operational taxonomic units (OTUs) and
higher levels of taxonomic assignment did not provide strong evidence of any single
taxa associated with AxSpA in the subgingival plaque.
Discussion. Although 16S rRNA gene sequencing did not identify specific bacterial
profiles associated with AxSpA, there remains the potential for the microbiota to exert
functional and metabolic influences in the oral cavity which could be involved in the
pathogenesis of AxSpA.
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INTRODUCTION
The term spondyloarthritis (SpA) is used to describe a spectrum of diseases which share
common clinical features and a common genetic predisposition. Ankylosing spondylitis
(AS) is the archetypal clinical phenotype (Khan, 2002). The strong familial association
amongst close relatives with AS is linked with the allele HLA-B27 present in approximately
90% of individuals with AS (Roberts et al., 2013). In 2009 the Assessment of Spondy-
loArthritis international Society (ASAS) proposed new nomenclature for SpA, based on
classification criteria (Rudwaleit et al., 2009), which has changed the perspective of anky-
losing spondylitis (AS) (Van der Horst-Bruinsma, 2013). The axial form of SpA (AxSpA)
is now subdivided in the (early) non-radiographic type (nr-axial SpA) and the radiographic
type, which equates to AS (according to the older modified New York criteria (Van der
Linden, Valkenburg & Cats, 1984)). The advantage of the new nomenclature is that it
encompasses patients with earlier and less severe disease, and reflects the spectrum of
severity seen in clinical practice.
A role for intestinal inflammation in the aetiology of AxSpA is suggested by an association
with inflammatory bowel disease (IBD), where 20% of patients develop features of SpA
(Mielants et al., 1995). In order to investigate aetoiological mechanisms associated with
genetic predisposition in AxSpA, transgenic murine models expressing human HLA-B27
have been derived. These animals develop inflammation of the peripheral joints and spine
and also develop colitis (Hammer et al., 1990). It is thought that the microbiome plays
a role in disease pathogenesis, since germfree HLA-B27 transgenic rats do not develop
arthritis (Taurog et al., 1994). However, arthritis develops when commensal bacteria, such
as Bacteroides vulgatus, are introduced into these germfree models (Rath et al., 1996).
While the gastrointestinal tract harbours the largest microbiome in humans, other
sites have microbial populations which are believed to significantly influence human
health; in particular, the oral cavity harbours over 700 bacterial species. Although dental
plaque represents a relatively small biomass, it is characterized by a highly dense microbial
community which is almost as diverse as those found in the intestinal tract (Costello et al.,
2013; HMPConsortium, 2012). Additionally, when periodontal inflammation is evident,
the junctional epithelium has greater permeability, with resultant challenge to microbial
tolerance and immunogenicity (Ohlrich, Cullinan & Seymour, 2009).
Periodontal disease is characterised by inflammation of the gingival tissues of the
teeth and progressive loss of alveolar bone, resulting in apical migration of the epithelial
attachment forming a periodontal pocket between the tooth root and the gingiva, thus cre-
ating an anaerobic environment (Pihlstrom, Michalowicz & Johnson, 2005). Epidemiologic
studies show that as many as 10% to 15% of the adult population have severe or advanced
periodontitis (Petersen & Ogawa, 2005). The oral microbiota has a role in periodontal
disease and, in turn, is thought to play a contributory role in chronic systemic inflammatory
diseases (Pizzo et al., 2010). For instance, patients with rheumatoid arthritis (RA) have a
higher prevalence of severe periodontitis and tooth loss than healthy controls (De Pablo,
Dietrich & McAlindon, 2008) and the severity of periodontal disease correlates positively
with disease activity in RA (Ribeiro, Leão & Novaes, 2005; Loyola-Rodriguez et al., 2010).
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The composition of the oral microbiota also appears to be a factor in RA (Yeoh et al., 2013)
and treatment of periodontitis ameliorates RA disease activity (Ortiz et al., 2009). It is
noteworthy that periodontal pathogens have been detected in the synovial fluid of patients
with RA and AxSpA (Kempsell et al., 2000;Martinez Martinez et al., 2009;Moen et al., 2005;
Moen et al., 2006).
We hypothesize that the microbiota present in dental plaque, which lies in close
association with inflamed gingival tissue, allows bacterial components to trigger or
perpetuate the inflammatory process in a genetically susceptible host with AxSpA. In order
to test this hypothesis, we aimed to investigate the diversity of the microbiome in patients
with AxSpA and compare this with healthy matched controls. In addition, we aimed to
discover whether particular components of the oral microbiota were deferentially abundant
in patients with AxSpA than in healthy individuals, to ascertain whether individual bacteria
could be implicated in the pathogenesis of AxSpA.
MATERIALS & METHODS
Participants and sample collection and design
The pilot study used a matched case-control design. The case group comprised 17 with
axial SpA as defined by the Assessment in Spondyloarthritis International Society (ASAS)
criteria for AxSpA (Rudwaleit et al., 2010). These criteria were chosen to provide a sample
with a wider range of disease duration and severity than would have been obtained using
the modified New York criteria for AS. Patients were randomly selected from those
attending the Rheumatology Department at Dunedin Hospital, New Zealand. Participants
in the control group were purposively selected from the Electoral Roll and invited by
post to participate in the study. They were individually matched to AxSpA patients on
the characteristics of age (within two years), gender and ethnicity. In total 317 potential
participants were identified from electoral roll. A total of 108 replied to letters sent out
and of these, 53 volunteered to participate. Of the 55 who did not participate, 43 declined
and six were not eligible due to exclusion criteria. Exclusion criteria for healthy controls
were as follows: unable to provide informed consent, pregnancy, history of malignancy,
taking anticoagulants, previous history of periodontal treatment, edentulous, history of
inflammatory arthritis (including AxSpA), osteoporosis, significant cardiovascular disease,
diabetes mellitus or inflammatory bowel disease.
All participants gave written informed consent in accordance with the Declaration of
Helsinki, and ethical approval for the study was obtained from the Lower South Regional
Ethics Committee, New Zealand (ref: LRS/10/06/020).
In the AxSpA patient group, all participants attended for clinical examination. Disease
activity was measured using the Bath Ankylosing Spondylitis (BAS) disease activity index
(BASDAI) (Garrett et al., 1994). All patients with AxSpA were genotyped for HLA-B27 and
had a blood test at the time of sampling to measure C-reactive protein (mg/L). Recent
radiographs were reviewed. All participants were surveyed about their smoking status.
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Oral examination
All participants underwent a detailed clinical oral examination following the World Health
Organization (WHO) manual of oral diseases assessment (Kramer, Pindborg & Infirri,
1980). The principal examiner (PS) underwent calibration prior to clinical data collection
with intra-examiner calibration (with ten volunteers not recruited to the study). Data
collected included: probing pocket depth (PPD) and gingival recession, clinical attachment
loss (CAL) and bleeding on probing (BOP) at six sites per tooth. Other clinical information
recorded included assessment of plaque deposits, oral mucosal conditions, and dental
caries status: including enumeration of decayedmissing or filled teeth (DMFT). The clinical
assessor was not formally blinded to the status of the participant (AxSpA or control), this
was impractical as many of the patient group had very obvious clinical features of AxSpA.
Periodontitis was defined in this study as PPD ≥ 4 mm at ≥4 sites. There is considerable
variation in the definition of periodontitis and no international consensus (Savage et al.,
2009). In this study a definition of periodontitis used for epidemiological studies and
defined by the Centre for Disease Control was selected (Eke et al., 2012). Observed clinical
differences between the two groups were tested for statistical significance in SPSS (Version
21), using (as appropriate) Mann–Whitney U -tests and Chi-square tests, with an alpha
value of 0.05.
Plaque sampling and DNA extraction
Plaque accumulation was assessed to determine the oral hygiene status of AxSpA patients
and controls. A plaque score was recorded for the buccal, palatal and lingual surfaces of all
teeth except the thirdmolars (Silness & Löe, 1964). Subgingival plaque was sampled from all
interproximal sites and placed in phosphate-buffered saline for storage at−20 degrees prior
to analysis. Plaque sampled from different sites was pooled into a single sample for each
individual. Plaque samples were centrifuged for 5 min at 13,000× g and the supernatant
removed. Bacterial DNA was extracted using the Purelink Genomic DNA kit (Invitrogen,
Carlsbad, CA, USA) according to the manufacturer’s protocol for Gram-positive bacteria.
Microbiota analyses
PCR of the V6 region of the 16S rRNA gene, sequencing and demultiplexing of sequencing
reads was carried out as before using the Ion Torrent platform (Bisanz et al., 2014a;
Bisanz et al., 2014b). Briefly, The primers used were CCATCTCATCCCTGCGTGTCTCC-
GACTCAGXXXXXCWACGCGARGAACCTTACC and CCTCTCTATGGGCAGTCGGT-
GATACRACACGAGCTGACGAC with XXXXX being a sample specific index. 25 cycles of
PCR were carried out using GoTaq Colorless Master Mix (Promega) and amplicons were
confirmed by gel electrophoresis. Amplicons were quantified and pooled at equimolar
concentration using Qubit HSDNA (Life Technologies) before clean up (QIAquick PCR
Purification kit). The resulting pool was sequenced at the London Regional Genomics
Centre according to standard protocols using an Ion Torrent 316 chip. Raw reads are
available in the NCBI Short Read Archive (accession: SRX513907) and the pipeline for
demultiplexing and processing is available at github.com/ggloor/miseq_bin. Reads were
filtered to only those containing perfect primer sequences, barcodes and a length between 70
Bisanz et al. (2016), PeerJ, DOI 10.7717/peerj.2095 4/15
and 90 for the V6 region. Taxonomy was assigned to operational taxonomic units (OTUs;
97% clustering) using the RDP classifier. α and β-diversity analysis and subsequent
OTU level associations were made using the VEGAN and GUniFrac R Packages (Chen
et al., 2012; Oksanen et al., 2016). To control for uneven sampling depth, all samples
were subsampled to 9,064 reads. To examine differentially abundant taxa and to avoid
spurious correlations common with the use of Pearson’s correlation and proportional
data (Pearson, 1896), ALDEx2 (version 2.0.6) (Fernandes et al., 2013; Fernandes et al., 2014)
was used to calculate the centered-log ratio (CLR) of each OTU within a sample from
raw read counts. Additionally, this approach includes an estimation of technical variation
common to microbiota datasets by randomly drawing Monte-Carlo instances from the
Dirichlet distribution. Stringent multiple test correction was applied using Benjamini
Hochberg false discovery rate. Associations were then examined in R software using
Pearson’s correlation coefficient. Differential abundance of taxa was represented in an
effect plot (Gloor, Macklaim & Fernandes, 2015). To completely recapitulate analysis, the
raw code for read processing and analysis, associated metadata, and OTU table (.biom
format) are available at github.com/jbisanz/ankspon.
RESULTS
Clinical and demographic characteristics of patients and controls
Demographic and disease characteristics of the 17 patients with AxSpA are presented in
Table 1. Of the 17 patients, 14 fulfilled the older modified New York Criteria for ankylosing
spondylitis (AS). Four patients with AS had additional SpA spectrum associated diseases
including: two with psoriasis and two with inflammatory bowel disease. No patients had
a history of reactive arthritis. The mean age of patients was 38 years and of controls was
37 years. Amongst AxSpA patients, disease activitymeasured by the BASDAI disease activity
score showed a mean of 4.0, indicating a group with active disease; although a wide range
of disease activity was recorded, with scores ranging from 0.2 to 8.9. Summary data on the
two groups’ oral disease characteristics are presented in Table 2. Patients with AxSpA were
significantly more likely than controls to have clinically relevant periodontal disease (PPD
≥ 4 mm at ≥4 sites), more bleeding on probing and a higher mean plaque index.
The plaque microbiota in AxSpA patients and controls
16S rRNA community profiling of the plaque samples yielded high sequencing depth, with
the mean number of quality-filtered reads per sample being 51,203 (range 10,041–82,541,
SD 13,549). Clustering was carried out at 97% identity to yield 127 distinct OTUs at
≥1% abundance in at least one sample with an average length of 75 bp after removal
of primer and bar code sequences. The OTUs were summarized to the family level and
are displayed in Fig. 1. At the family level, the most abundant families across all samples
were the Prevotellaceae (13.6%), Streptococcaceae (12.3%), Veillonellaceae (12.1%),
Corynebacteriaceae (8.0%) and Actinomycetaceae (6.1%). At the phylum level, the most
dominant phyla across all samples were the Firmicutes (28.2%), Bacteroidetes (22.5%) and
Actinobacteria (19.3%), with the TM7 phylum being present at 0.3%.
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Table 1 Characteristics of AxSpA participants and healthy controls.
Variable
(number unless otherwise stated)
AxSpA patients
(n= 17)
Healthy controls
(n= 22)
Female 6 (35.3) 7 (31.8)
Mean age (years; SD) 38.0 (12.8) 37.0 (12.7)
General health
Cardiovascular disease 11 (64.0) 0
Diabetes 1 (2.4) 0
Inflammatory bowel disease 4 (9.8) 0
Smoking status
Never smoker 14 (82.4) 13 (59.1)
Ex-smoker 3 (17.6) 6 (27.3)
Current smoker 0 (0.0) 3 (13.6)
Number HLA B27 positive 17 (100.0) –
Evidence of sacroiliitis on imaging
Radiographic 14 (76.5) –
MRI 2 (17.6) –
None apparent on imaging 1 (5.8) –
Mean BASDAI (SD) 4.0 (2.1) –
Mean CRP (mg/L; SD) 5.4 (5.3) –
Notes.
Brackets contain percentages unless otherwise specified.
BASDAI, Bath Ankylosing Spondylitis Disease Activity Index; CRP, C-reactive Protein.
Table 2 Oral health characteristics of AxSpA patients and healthy controls.
Variable
(number unless otherwise stated)
AxSpA patients
(n= 22)
Healthy controls
(n= 17)
p-value
Mean decayed missing or filled teeth 13.1 (7.6) 9.9 (7.6) 0.210
Number of individuals with ≥4 sites with
PPD ≥ 4 mm (%)
11 (64.7) 5 (22.7) 0.008
Mean number of sites with PPD ≥ 4 mm 5.6 (5.1) 5.1 (11.5) 0.146
Mean number of sites with CAL ≥ 4 mm 10.1 (13.4) 12.6 (25.1) 0.318
Mean number of sites with bleeding on
probing
36.6 (21.3) 23.6 (17.6) 0.041
Mean plaque index score 1.0 (0.4) 0.6 (0.4) 0.006
Number meeting CDC severe periodon-
titis definition (%)
1 (0.1) 2 (0.1) 0.709
Notes.
Brackets contain standard deviations unless otherwise indicated.
PPD, Pocket Probing Depth; CAL, Clinical attachment loss.
To address howmicrobial communities may differ between AxSpA and healthy controls,
we applied multiple metrics of both α and β diversity (Fig. 2). No alpha diversity
metric showed a difference in richness or evenness of communities (Figs. 2A–2C) and
no beta diversity metric showed clear clustering by community composition by principal
coordinates analysis, which was statistically corroborated by ANOSIM analysis (p> 0.05).
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Figure 1 Heatmap of family-level abundances (calculated post-OTU filtering) of the subgingival plaque microbiome in AxSpa and healthy
controls.
Given that the microbiota in AxSpA patients and controls does not appear to differ at
the community level, the analysis focused on individual OTUs and higher level taxonomic
assignments (from phylum to species level) associated with both AxSpA and disease activity
(BASDAI) in these individuals. No OTUs were associated with AxSpA, based on the robust
approach applied with a stringent false discovery rate cutoff. Features were plotted in the
context of an effect plot (Gloor, Macklaim & Fernandes, 2015) demonstrating minimal
difference between conditions (Fig. 3). The Actinobacteria phylum (unadjusted p= 0.04)
was found to be higher in relative abundance in healthy controls, however this was not
significant after multiple testing correction.
Next, in order to investigate the role of the microbiome constituents in disease activity,
analysis focused on associations between OTUs (CLR-normalized) and disease activity
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Figure 2 α and β diversity analysis of differences between AxSpa and healthy control communities.
Three measures of α diversity (Shannon’s (A), Simpson’s (B), and Chao1 (C)) all fail to report a signifi-
cant difference between disease states in terms of organism richness and evenness (Wilcox rank sum p >
0.05). Similarly, three measures of β diversity (both phylogenetic (E, F)/non-phylogenetic (D) and with
(D, E) and without abundance weighting (F)) do not visually or significantly (ANOSIM p > 0.05) report
differences between communities.
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Figure 3 Differential abundance of features (OTUs and higher-level taxonomic assignments) shows a
single feature (Actinobacteria; unadjusted p = 0.04) is higher in healthy controls, however this is not
significant after multiple testing correction. Each point represents a feature (taxa) while the Y -axis de-
notes the difference between healthy controls and AxSpA and the X-axis denotes the dispersion within
groups. The broken lines demonstrate the case where difference between groups is equal to the dispersion
within groups, and thus significant results would be expected to be found outside of the central area of the
plot.
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Table 3 Correlation analysis of CLR-normalized OTU abundances with the oral health (PPD≥ 4 mm
at≥4 sites).
OTU # FDR r2 Taxonomic assignment
13 0.007 −0.619 Streptococcus spp.
150 0.007 0.619 Saprospira spp.
0 0.014 −0.586 Actinomyces spp.
21 0.08 −0.522 Actinomyces massiliensis
(BASDAI), quality of life (ASQoL), and systemic inflammation (C-reactive protein)
among the individuals with AxSpA. No associations were found with levels of C-reactive
protein or BASDAI. Significant correlations (p> 0.05, r < 0.5) were found between 4 taxa
and ASQoL; however, these were strongly influenced by a single individual and thus of
doubtful validity. When this individual was removed from the analysis, the differences
were no longer statistically significant. OTU relative abundances (CLR-normalized) were
correlated with periodontal disease (PPD ≥ 4 mm at ≥4 sites) and examined across
pooled data from healthy control participants and those with AxSpA (Table 3). Significant
associations were apparent (FDR < 0.1) with high abundance taxa including Streptococcus
spp. and Actinomyces spp.
DISCUSSION
To our knowledge, this is the first study to examine oral plaque bacterial communities in
relation to oral health in patients with AxSpA using high-throughput DNA sequencing
techniques. At the community level, we found no difference between AxSpA patients and
healthy controls in either their community structure or in the diversity of organisms in the
plaque bacterial communities analyzed. This is despite the confounders that patients with
AxSpA had significantly worse oral health than age- and sex-matched controls, with more
plaque and a higher prevalence of periodontitis, despite their young mean age. In a similar
study examining the oral microbiome in patients with RA, no difference in community
profile was found amongst early RA, chronic RA and healthy controls, but differences in
the subgingival microbiota were noted in relation to periodontitis (Scher et al., 2012).
Analysis at the OTU level failed to demonstrate an association between AxSpA and
several bacterial taxa with stringent multiple testing corrections. While this suggests that
no single causative-agent in the subgingival plaque is involved in the aetiopathogenesis,
it should be noted that, without very many more samples, the sheer number of OTUs
compared would make it unlikely that small effect-sizes would be detected. This is
a limitation of the current study, and the data presented here should be viewed as a
discovery-based approach warranting replicating studies with greater enrollment in order
to conclusively rule out false negatives. All aspects of the data have been made publicly
available for those researchers wishing to use the data set for hypothesis generation. The use
of CLR-normalized relative abundances and modeling of technical error reduces the risk of
false associations with low-abundance taxa and spurious correlations frequently reported in
microbiota research (Fernandes et al., 2013; Fernandes et al., 2014). While being a relatively
Bisanz et al. (2016), PeerJ, DOI 10.7717/peerj.2095 9/15
new technology, 16S rRNA variable region surveys via high-throughput sequencing are
a relatively coarse method of analysis, and further studies using shotgun-metagenomic
and meta-RNA sequencing may provide more in-depth analysis that could discover strain
or gene-level associations with disease. Furthermore, given the growing evidence for an
association between periodontal disease and AxSpA (Keller, Kang & Lin, 2013; Pischon
et al., 2010), future studies should address the potential for the oral microbiota as a
causative factor in AxSpA, as opposed to being simply a marker of periodontal disease and
inflammation. This is particularly relevant given recent advances in our understanding
of the genetic predisposition to AxSpA. Potential mechanisms can only be postulated.
However, given evidence from elsewhere in the gut, it is possible that interactions between
the autologous microbiome and the host immune system may be implicated in the
aetiopathogenesis of AxSpA, since evidence for such a process in the ileo-colon continues to
accumulate (Costello et al., 2013). At present, there is limited objective evidence that either
specific bacteria or alterations in themicrobiome as a whole influence the aetiopathogenesis
of these conditions (Yeoh et al., 2013; Costello et al., 2013). Gingivitis and periodontitis are
both host immune responses to plaque microbial challenge (Seymour et al., 1988). Credible
biological mechanisms associating periodontitis and systemic inflammatory conditions
have been proposed, but epidemiological confirmation of a causal relationship remains
elusive. Associations are not necessarily causal andmay comprise but one aspect of a variety
of associated environmental risk factors (Seymour et al., 2007).
CONCLUSIONS
Plaque samples from patients with AxSpA showed no difference in microbial diversity
compared with matched controls, despite a higher prevalence of periodontitis. A wide
variety of taxa were identified in plaque samples, many of which have been identified in
previous studies both in the plaque of patients with periodontitis and in healthy individuals.
These findings require further evaluation in larger samples in order to investigate bacterial
community profiles and specific organisms of interest with reference to those identified in
this study. Further, microbial profiles in the oral cavity should be investigated with other
sites of interest including serum and synovial fluid specimens from patients with AxSpA.
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